About this document
Adjuvant Icotinib For Resected Egfr-Mutated Stage Ii-Iiia Non-Small-Cell Lung Cancer (Ictan, Gasto1002) : A Randomized Comparison Study by nrxdram875 is a document available to read on EtoBox.
The document discusses a randomized comparison study of adjuvant Icotinib for patients with resected EGFR-mutated stage II–IIIA non-small-cell lung cancer. It emphasizes the educational and research purposes of the material, which is compiled from various sources and not intended for commercial use. The document encourages users to verify intellectual property rights independently while allowing for educational redistribution.
- Author
- nrxdram875
- Language
- EN